Suzanne Trudel, Meral Beksac, Ludek Pour, Sosana Delimpasi, Hang Quach, Vladimir I. Vorobyev, Michele Cavo, Kazuhito Suzuki, Pawel Robak, Kristin Morris, Chee Paul Lin, Ianire Garrobo-Calleja, Giulia Fulci, Elisabet Manasanch, Brandon Kremer, María-Victoria Mateos, Meletios Athanasios Dimopoulos. "DREAMM-8 study of belantamab mafodotin plus pomalidomide and dexamethasone (BPd) vs pomalidomide plus bortezomib and dexamethasone (PVd) in relapsed/refractory multiple myeloma (RRMM): A subgroup analysis in patients with high-risk cytogenetic features.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.7533